Erector Spinae Block for Thoracic Surgery

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
George Washington University
Study ID
NCT05521789
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Pulmonary Cancer
  • Pulmonary Neoplasm
  • Thoracic Cancer
  • Thoracic Diseases
  • Thoracic Neoplasms

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • ESB Thoracic — DRUG
    Erector spinae thoracic block with bupivacaine

Study Details

The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.

Key Dates

Start date
Jul 22, 2022
Status verified
Feb 2026
Primary completion
Dec 21, 2026
Completion
Jul 21, 2027

Study Design

Enrollment
70 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Standard of Care + ESB Thoracic
    Patients randomized to this group will receive an erector spinae block in addition to the standard of care treatment
  • No Intervention: Standard of Care
    Patients randomized to this group will receive standard of care treatment and NO erector spinae block

Primary Outcome Measure

Outcome Measure - Pain Score and Pain Medications (6 hours) [ Time Frame: At 6 hours postoperatively ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The George Washington UniversityWashington D.C.District of Columbia20037
Anita Vincent
[email protected]
202-823-4228
Eduard Shaykhinurov
[email protected]
2028234259
Anita Vincent, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Washington D.C., DC

By research site
The George Washington University· Washington D.C., DC

Related Studies